Bo Yon Lee MD. PhD. Professor/ Chairman. Dept. OB/GYN Kyong Hee University Medical Center. Seoul, Korea.
Theses
S C I /E Journals :
Clinical manifestations in patients with ovarian clear cell carcinoma with or without co-existing endometriosis. Lim MC, Lee DO, Kang S, Seo SS, Lee BY, Park SY. Gynecol Endocrinol. 2009 Jul;25(7):435-40.
BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients. Lim MC, Kang S, Seo SS, Kong SY, Lee BY, Lee SK, Park SY. J Cancer Res Clin Oncol. 2009 Nov;135(11):1593-9.
Minimizing tumor burden by extensive cytoreductive surgery decreases postoperative venous thromboembolism in ovarian clear cell carcinoma. Lim MC, Lee HS, Kang S, Seo SS, Lee BY, Park SY. Arch Gynecol Obstet. 2010 Feb;281(2):329-34
Two dermoid cysts developing in an accessory ovary and an eutopic ovary. Lim MC, Park SJ, Kim SW, Lee BY, Lim JW, Lee JH, Huh CY. J Korean Med Sci. 2004 Jun;19(3):474-6.
Skin-Derived Stem Cells in Human Scar Tissues: A Novel Isolation and Proliferation Technique and Their Differentiation Potential to Neurogenic Progenitor Cells. Yang JH, Shim SW, Lee BY, Lee HT. Tissue Eng Part C Methods. 2010 Jan 23.
Derivation of embryonic germ cells from post migratory primordial germ cells, and methylation analysis of their imprinted genes by bisulfite genomic sequencing. Shim SW, Han DW, Yang JH, Lee BY, Kim SB, Shim H, Lee HT. Mol Cells. 2008 May 31;25(3):358-67
Fate of donor mitochondrial DNA in cloned bovine embryos produced by microinjection of cumulus cells. Do JT, Lee JW, Lee BY, Kim SB, Ryoo ZY, Lee HT, Chung KS. Biol Reprod. 2002 Aug;67(2):555-60.
In vitro development of reconstructed bovine embryos and fate of donor mitochondria following nuclear injection of cumulus cells. Do JT, Hong KH, Lee BY, Kim SB, Kim NH, Lee HT, Chung KS. Zygote. 2001 Aug;9(3):211-8.
Role of embryonic factors in human implantation. Polan ML, Simon C, Frances A, Lee BY, Prichard LE. Hum Reprod. 1995 Dec;10 Suppl 2:22-9
Immunohistochemical localization, identification and regulation of the interleukin-1 receptor antagonist in the human endometrium. Simon C, Frances A, Lee BY, Mercader A, Huynh T, Remohi J, Polan ML, Pellicer A. Hum Reprod. 1995 Sep;10(9):2472-7.
Gonadal steroids modulate interleukin-1 receptor antagonist mRNA expression in cultured human monocytes. Lee BY, Huynh T, Prichard LE, McGuire J, Polan ML. Biochem Biophys Res Commun. 1995 Apr 6;209(1):279-85
Domestic Journals :
Retrospective study of functional ovarian cysts on ultrasonographic findings. ÃÊÀ½Æİ˻翡¼ ±â´É¼º ³¼Ò³¶Á¾À¸·Î º¸À̴ ȯÀڵ鿡 ´ëÇÑ ÈÄÇâÀû °íÂû. ÀÌ¿µ¹Î. Á¤³Èñ. À̺¸¿¬. ´ëÇÑ»êºÎÀΰúÇÐȸ ÀâÁö. 2009. 52; 7: 746-751
Clinical implication of salivary cortisol levels in pregnancy. ÀӽŠÁß Å¸¾×³» ÄÚ¸£Æ¼Á¹ ³óµµ º¯ÈÀÇ ÀÓ»óÀû ÀÇÀÇ. Á¤ÀÇ. À̺¸¿¬. ±è½Âº¸. ´ëÇÑ»êºÎÀΰúÇÐȸ ÀâÁö. 2009. 52; 12: 1252-1257
Comparison of the efficacy of additional vaginal dressing disinfectants for reduction of wound-related complications in laparoscopic hysterectomy. º¹°°æ¼ú½ÄÀ» ÀÌ¿ëÇÑ ÀÚ±ÃÀýÁ¦¼ú¿¡¼ â»ó °ü·Ã ÇÕº´Áõ °¨¼Ò¸¦ À§ÇØ ½ÃÇàÇÑ Ãß°¡ÀûÀÎ Áú¼Òµ¶Á¦ÀÇ È¿¿ë¼º ºñ±³. ÀÌ¿µ¹Î. ±è½Å¿µ. Á¤¹ÎÇü. À̺¸¿¬. ÇãÁÖ¿±. ´ëÇÑ»êºÎÀΰúÇÐȸ ÀâÁö. 2008. 51; 5: 563-567
A study of stress reactivity in the development of chronic endometriosis. Àڱ󻸷Áõ ȯÀÚ¿¡¼ Ÿ¾× ³» ÄÚ¸£Æ¼Á¹ ³óµµ¸¦ ÀÌ¿ëÇÑ ½ºÆ®·¹½º¿Í Áõ»ó°úÀÇ »ó°ü°ü°è¿¡ ´ëÇÑ ¿¬±¸. ÀÌÁöÀº Á¤¹ÎÇü, À̺¸¿¬, ±è½Âº¸, ÇãÁÖ¿±. ´ëÇÑ»êºÎÀΰúÇÐȸ ÀâÁö. 2007. 50; 1: 187-194
A case of Sertoli-Leydig cell tumor with mucinous heterologous element in a postmenopausal woman. Æó°æ ÈÄ ¿©¼º¿¡°Ô ¹ß»ýÇÑ Á¡¾×¼º ÀÌÇüÀ¯·¡¿ä¼Ò°¡ ÀÖ´Â Sertoli-Leydig ¼¼Æ÷Á¾ 1¿¹. ÀÌÇö¼®, ±èÀ±È, Á¤¹ÎÇü, À̺¸¿¬, ÇãÁÖ¿±. ´ëÇÑ»êºÎÀΰúÇÐȸÀâÁö. 2007. 50; 6: 936-939
Transvaginal sonography guided aspiration of ovarian cyst suspected torsion in early pregnancy:A case report . ÀÓ½ÅÃʱ⠿°ÀüÀÌ ÀǽɵǴ ³¼Ò ³¶Á¾ÀÇ Áú½Ä ÃÊÀ½ÆÄÀ¯µµ ÈíÀμú 1¿¹. ¹Ú¼ºÀç, Á¤ÀÇ, À̺¸¿¬. ´ëÇÑ»êºÎÀΰúÇÐȸÀâÁö. 2007. 50; 8: 1175-1179
The Follicular Fluid and Serum Concentrations of Vascular Endothelial Growth Factor in patients during IVF-ET Cycles. ü¿Ü¼öÁ¤ ȯÀÚ¿¡¼ÀÇ ³Æ÷¾× ¹× Ç÷Áß Ç÷°ü ³»ÇÇ ¼ºÀåÀÎÀÚ. ¹Ú¼ºÀç, ±â°æµµ, ÀÌÈ¿¿ø, À̺¸¿¬, À̼±°æ, ÇãÁÖ¿±, ±è½Âº¸. ´ëÇÑ»êºÎÀΰúÇÐȸÀâÁö. 2006. 49; 9: 1941-1948
Simultaneous occurrence of a granulosa cell tumor and a serous cystadenoma in the same ovary:A case report . Àå¾×¼º ³¶¼±Á¾°ú µ¿¹ÝµÈ °ú¸³¸· ¼¼Æ÷Á¾. ÇÏâ¿í, ÀÓ¸íö, ÃÖ¿µÁØ, À̺¸¿¬, À̼±°æ, ÇãÁÖ¿±, ±è½Âº¸, ±èÀ±È, ÀÓÁÖ¿ø. ´ëÇÑ»êºÎÀΰúÇÐȸÀâÁö. 2006. 49; 12: 2652-2655
A case of myasthenia gravis aggravated and diagnosed after repeat cesaerian section . ¹Ýº¹Á¦¿ÕÀý°³¼ö¼ú ÈÄ ±Ù¹«·ÂÁõÀÌ ¾ÇȵǾî Áø´ÜµÈ 1¿¹. ±èÀ±¿µ, ÃÖ¿µÁØ, À̺¸¿¬, À̼±°æ, ÇãÁÖ¿±, ±è½Âº¸. ´ëÇÑ»êºÎÀΰúÇÐȸÀâÁö. 2005. 48; 2: 473-479
A Case of Prenatally Diagnosed Jacobsen syndrome . »êÀü¿¡ Áø´ÜµÈ Jacobsen ÁõÈıº 1¿¹. À±ÀçÈñ, ±è¼Ò¶ó, ÀÌ¿ìÀÎ, À̺¸¿¬, À̼±°æ, ÇãÁÖ¿±, ±è½Âº¸. ´ëÇÑ»êºÎÀΰúÇÐȸÀâÁö. 2005. 48; 5: 1358-1362
The Effect on Pain of Waiting between Paracervical Block and Procedure in Dilatation &Curettage. ¼ÒÆļú½Ã ÀڱðæºÎÁÖÀ§ Â÷´Ü¸¶Ãë ÁÖ»çÈÄ ½Ã¼ú±îÁöÀÇ Áö¿¬½Ã°£ÀÌ ÅëÁõ¿¡ ¹ÌÄ¡´Â ¿µÇâ . ÀÓ¸íö, À̼®Èñ, Àå¹Ì°æ, À̺¸¿¬, ±è°Ç½Ä, À̼±°æ, ÇãÁÖ¿±, ±è½Âº¸. ´ëÇÑ»êºÎÀΰúÇÐȸÀâÁö. 2004. 47; 5: 952-956
Recurrent Abortion :Etiology and management. ¹Ýº¹À¯»êÀÇ ¿øÀΰú Ä¡·á. À̺¸¿¬, ´ëÇÑ »êºÎÀΰúÇÐȸ ±³À°°¿¬/»ý½Ä³»ºÐºñºÐ¾ß,2004,74.80
ü¼¼Æ÷ ÇÙġȯ ¿¬±¸ÀÇ ÀÇÀÇ. À̺¸¿¬. °æÈñÀÇÇÐ. 2003 19:1:7-11
A case of Intraperitoneal Hemorrhage of Intraligamentous Pregnancy. º¹°³» ÃâÇ÷À» µ¿¹ÝÇÑ ±¤Àδë ÀӽŠ1 ¿¹. ³ëµ¿±Ô,¼»ó±â,Á¤¹ÎÇü,À̺¸¿¬,±èºÀÈñ,±è½Âº¸. ´ëÇÑ»êºÎÀΰúÇÐȸÀâÁö. 2002. 45; 8: 1389-1392
Pelviscopic ovarian drilling in infertile patients with polycysticovarian syndrome resistant to Clomiphene citrate. Ŭ·Î¹ÌÆæ¿¡ ¹ÝÀÀÇÏÁö ¾Ê´Â ´Ù³¶¼º ³¼ÒÁõ ºÒÀÓ È¯ÀÚ¿¡¼ °ñ¹Ý°æ ³¼Ò ¼ÒÀÛõ°ø¼ú. À̺¸¿¬,ÀüÇý¼÷,±è½Âº¸ . ´ëÇÑ»êºÎÀΰúÇÐȸÀâÁö. 2000. 43; 11: 2033-2037
A Clinical Study of Comparison with Success Group and Failure Group in Vaginal Birth after Cesarean Delivery. ¼±Çà Á¦¿ÕÀý°³ ÈÄÀÇ Áú½Ä ºÐ¸¸½Ã ¼º°ø±º°ú ½ÇÆбºÀÇ ºñ±³¿¬±¸. ÃÖÇö¼ö,ÀÌ»ó¿í,¿À¿µ½Â,Áø±Ô¼·,À̺¸¿¬,À̼±°æ,ÇãÁÖ¿±,±è½Âº¸. ´ëÇÑ»êºÎÀΰúÇÐȸÀâÁö. 1999. 42; 10: 2281-2286
ü¼¼Æ÷ ÇÙġȯÀ» ÅëÇÑ »ý¸íº¹Á¦ °øÇб³À°°ú ±â¼ú :Çѱ¹°øÇбâ¼úÇÐȸ ÀâÁö, 1999³â 3¿ù È£ 97-100
¼Ò¿¡¼ÀÇ ¹Ì¼¼ÁÖÀÔ¿¡ ÀÇÇÑ ÇÙġȯÀÌÈÄ ÇÙ°ú ¹Ì¼¼¼Ò°üÀÇ º¯È :µµÁ¤ÅÂ,À̺¸¿¬, ÀÌÈÆÅÃ, Á¤±æ»ý, ±è½Âº¸: ¹ß»ý°ú »ý½Ä 3:2 (1999)
³¼ÒÀÇ ³ëÈ (Á¾¼³): À̺¸¿¬. ´ëÇÑÆó°æÇÐȸÀâÁö. 1999. 6;5:2 129-134
¹è¾çµÈ Àΰ£ Àڱ󻸷¿¡¼ vitronectin receptorÀÇ ¹ßÇö. ¿¬¼¼´ëÇб³ÀÇ°ú´ëÇпø:¹Ú»ç³í¹® (1998³â 6¿ù 5ÀÏ)
Àڱ󻸷 interleukin-1 receptor type I ÀÇ Á¶Àý. À̺¸¿¬ À±ÇöÇÏ ±è½Âº¸ ´ëÇÑ»êºÎÀΰúÇÐȸÁö 1998;41(2):483-488
ÀӽŠÁß±â Á¶±â ¾ç¸·Æļö°¡ ÀÏ¾î³ »ê¸ðÀÇ ¼º°øÀûÀÎ ºÐ¸¸ 1 ¿¹. Á¶À±Á¦. À̺¸¿¬, ÃÖÇö¿ì, À̼±°æ, ÇãÁÖ¿±, ±è½Âº¸. ´ëÇÑ»êºÎÀΰúÇÐȸÁö 1998:41(9):2476-2479
¼Ò ³ÀÚ¿¡ ÀÖ¾î¼ ¼¼Æ÷Áú³» Á¤ÀÚ Á¤ÀڵκΠ¹ÌºÎ ÁÖÀÔÈÄ ¹Ì¼¼¼Ò°ü°ú ¿°»öÁúÀÇ ±¸Á¶º¯È. µµÁ¤ÅÂ, Àü¼öÇö, ÃÖÁ¾ÅÂ, °¿µ¼±, À̺¸¿¬, ±è½Âº¸, ±è³²Çü, ÀÌÈÆÅÃ, Á¤±æ»ý. ´ëÇѺÒÀÓÇÐȸÀâÁö, 1997:24(3):301-310
Ç×¾ÏÈÇпä¹ýÀ» ¹ÞÀº ºÎÀÎ¾Ï È¯ÀÚÀÇ Ç÷¾×ÇÐÀû ºÐ¼®À» ÅëÇÑ ÀÓ»óÀû °íÂû. ±è¼±È£, ±èÀÀ¼±, Áø±Ô¼·, À̺¸¿¬, À̼±°æ, ÇãÁÖ¿±, ±è½Âº¸. ´ëÇѺÎÀÎÁ¾¾çÄÝÆ÷½ºÄÚÇÇÇÐȸÀâÁö 1997:8:3; 291-299
ÁßÁõ ±Ù¹«·ÂÁõÀÌ µ¿¹ÝµÈ ¸¸»èÀӽŠ1·Ê. À±´ë½Ä, À̺¸¿¬ À̼±°æ, ÇãÁÖ¿±, ±è½Âº¸, ÀÌÀçÇö. ´ëÇÑÁÖ»ê±â ÇÐȸÀâÁö. 1997:8:2 201-206
³ë·É ºÒÀÓȯÀÚ¿¡¼ ³ÀÚ³»Á¤ÀÚÁÖÀÔ¼ú. À̺¸¿¬. °æÈñÀÇ·á¿øº¸ 1997 10.
Àڱ󻸷¼¼Æ÷¿Í ¿µ¾ç¸·¼¼Æ÷ÀÇ Ã¼¿Ü°øµ¿¹è¾ç. À̺¸¿¬, ±è½Âº¸. ´ëÇÑ»êºÎÀΰúÇÐȸÁö 1997 40:6: 1171-1177
»êºÎÀΰúÀû Ãø¸é¿¡¼ º» ¼º±â´É Àå¾Ö, À̺¸¿¬. °æÈñÀÇÇÐ 1996. 12:1
ŹÝÁ¶±â¹Ú¸®¿¡ ´ëÇÑ ÀÓ»óÀû °íÂû. ±èÀÀ¼± Á¤¼øÀÚ À̺¸¿¬ À̼±°æ ±è½Âº¸ ´ëÇÑ»êºÎÀΰúÇÐȸÁö 1996 39: 2167
Àڱðæ°ü ¹«·ÂÁõ¿¡ °üÇÑ ÀÓ»óÀû °íÂû. º¯Á¾¿ø °ûÈñÁß À̺¸¿¬ À̼±°æ ±è½Âº¸ ÀÌÀçÇö. ´ëÇÑ»êºÎÀΰúÇÐȸÁö 1996:39: 1636
ÀӽŰú µ¿¹ÝµÈ ³¼ÒÁ¾¾ç. ¿ëâÀÓ ½ÅÁø¿Á À̺¸¿¬ À̼±°æ. ´ëÇÑ»êºÎÇÐȸÁö 1996:39 1257
¼º¼÷ ³¼Ò°ú¸³¼¼Æ÷¿¡¼ÀÇ Ç¥ÇǼº ¼ºÀåÀÎÀÚ ºÐºñ¿Í ¼ºÀå È£¸£¸óÀÌ ÀÌ¿¡ ¹ÌÄ¡´Â ¿µÇâ. À̺¸¿¬ ¹Ú±âÇö Á¶µ¿Á¦ Ȳµ¿ÈÆ ¼ÛÂùÈ£. 1994:37:1 63-66 ´ëÇÑ»êºÎȸÁö
Hypogonadotropic hypogonadism ȯÀÚ¿¡ ÀÖ¾î¼ ³»Àμº ¼ºÀåÈ£¸£¸óÀÌ hMG¸¦ ÀÌ¿ëÇÑ ¹è¶õÀ¯µµ¿¡ ¹ÌÄ¡´Â ¿µÇâ. À̺¸¿¬ ¹Ú±âÇö À̺´¼® ¼ÛÂùÈ£. 1993:36:7 (SI)1158-1162 ´ëÇÑ»êºÎȸÁö
°æÇÇÀû ¿¡½ºÆ®·ÎÁ¨À» ÀÌ¿ëÇÑ Æó°æ±â ÁõÈıºÀÇ Ä¡·á½Ã Ç÷Áß ÁöÁú ´ë»çÀÇ º¯È. À̺¸¿¬ Á¤¹ÌÁ¤ ¹Ú±âÇö À̺´¼® Á¶µ¿Á¦ Ȳµ¿ÈÆ ¼ÛÂùÈ£. 1993:36:7 (SIII) 1875-1881 ´ëÇÑ»êºÎȸÁö
GnRH-a¸¦ ÀÌ¿ëÇÑ ÀڱñÙÁ¾ÀÇ Ä¡·á°¡ ±ÙÁ¾ Á¶Á÷³» Epidermal growth factor ¼ö¿ëü¿¡ ¹ÌÄ¡´Â ¿µÇâ. À̺¸¿¬ À̺´¼® ¹Ú±âÇö Á¶µ¿Á¦ ¼ÛÂùÈ£ ¾ç¿ìÀÍ. 1993:36:7 (SIII) 1919-1923 ´ëÇÑ»êºÎȸÁö
ÀڱðæºÎ ´Ü´Ü¾Ï. À̺¸¿¬ ¹ÚÂù±Ô ±èÀç¿í ÃÖµ¿Èñ. 1992:35:7 1012-1017 ´ëÇÑ»êºÎȸÁö
AchondrogenesisÀÇ »êÀü Áø´Ü 1¿¹. ±è¼¼±¤ À̺¸¿¬ ¹Ú¿ë¿ø ¾ç¿µÈ£ ¼ÛÂùÈ£. 1992:35:9 1396-1400 ´ëÇÑ»êºÎȸÁö
hMG¸¦ ÀÌ¿ëÇÑ ¹è¶õ À¯µµ½Ã ¼ºÀå È£¸£¸ó°ú somatomedin-C°¡ ³Æ÷ ¼ºÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ. ¹Ú±âÇö ¹Ú¿øÀÏ À̺¸¿¬ À̺´¼® Á¶µ¿Á¦ ¼ÛÂùÈ£. 1993:36:7 1908-1912 ´ëÇÑ»êºÎȸÁö
ºÒÀÓ ¿©¼ºÀÇ Àڱà °æ°ü Á¡¾×³» IgA Ç×Á¤ÀÚ Ç×ü¿¡ °üÇÑ ¿¬±¸. À̺´¼®,¹Ú±âÇö,À̺¸¿¬,Ȳµ¿ÈÆ,¼ÛÂùÈ£ 1989:32:8 1032 ´ëÇÑ»êºÎȸÁö
Æó°æÀü ¹«¿ù°æ ¿©¼º¿¡ ÀÖ¾î¼ °ñ¹Ðµµ ÃøÁ¤¿¡ °üÇÑ ¿¬±¸. ¹Ú±âÇö À̺´¼® À̺¸¿¬ Á¶µ¿Á¦ ¼ÛÂùÈ£. 1992:19:1 49-56 ´ëÇѺÒÀÓÇÐȸÁö
GnRH ÀÇ ¸Æµ¿¼º Åõ¿©¿¡ ÀÇÇÑ ³²¼º ¼º¼± ±â´É ÀúÇÏÁõÀÇ Ä¡·á. ¹Ú±âÇö Áö¿ë¼® À̺´¼® À̺¸¿¬ Á¶µ¿Á¦ ¼ÛÂùÈ£. 1992:19:1 81-85 ´ëÇѺÒÀÓÇÐȸÁö
¹«¿ù°æ½Ã GnRH ¹× TRH ÀÚ±Ø ½ÃÇè¿¡ ÀÇÇÑ ³úÇϼöü È£¸£¸ó ºÐºñ¾ç»ó¿¡ °üÇÑ ¿¬±¸.¼ÛÂùÈ£ À̺¸¿¬ À̺´¼® ¹Ú±âÇö Á¶µ¿Á¦. 1991:34:12 1677-1690 ´ëÇÑ»êºÎȸÁö
ÀڱñÙÁ¾½Ã LHRH agonist Ä¡·á¿¡ µû¸¥ ±ÙÁ¾ ¼¼Æ÷³» ¹Ì¼¼±¸Á¶ÀÇ º¯È. ¹Ú±âÇö ½Å¸íö À̺¸¿¬ À̺´¼® ¼ÛÂùÈ£. 1991:18:2 189-196 ´ëÇѺÒÀÓÇÐȸÁö
¹è¶õ À¯µµ½Ã ³»Àμº ¿¡½ºÆ®·ÎÁ¨ÀÌ Ä®½·´ë»ç¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ °üÇÑ ¿¬±¸. À±´Þ¿µ ¹Ú±âÇö À̺´¼® À̺¸¿¬ ¼ÛÂùÈ£. 1991:18:2 197-199 ´ëÇѺÒÀÓÇÐȸÁö
GnRH analogue¸¦ ÀÌ¿ëÇÑ ÀڱñÙÁ¾ÀÇ Ä¡·á½Ã ±ÙÁ¾Á¶Á÷³» ¿¡½ºÆ®·ÎÁ¨ ¹× ÇÁ·ÎÁ¦½ºÅ×·Ð ¼ö¿ëüÀÇ º¯È. ¹Ú±âÇö ¹Ú¿øÀÏ À̺¸¿¬ À̺´¼® Á¶µ¿Á¦ Ȳµ¿ÈÆ ¼ÛÂùÈ£. 1993:36:7 1913-1918 ´ëÇÑ»êºÎȸÁö
ºÒÀÓÁø´Ü¿¡ ÀÖ¾î¼ ³°ü°æÀÇ ÀÓ»óÀû ÀÌ¿ë. ¹Ú±âÇö ¹Ú¿øÀÏ À̺¸¿¬ À̺´¼® Á¶µ¿Á¦ ¼ÛÂùÈ£. 1993:20:1 95-98 ´ëÇѺÒÀÓÇÐȸÁö
ºÒÀÓȯÀÚÀÇ ¼¼Ã´Á¤ÀÚ¿¡ ´ëÇÑ Àڱó»Àΰø ¼öÁ¤ÀÇ ÀÓ»óÀû Æò°¡. À̽ÂÇå À±¿µ¿í À̺¸¿¬ À̺´¼® ¹Ú±âÇö Ȳµ¿ÈÆ. 1992:19:1 65-69 ´ëÇѺÒÀÓÇÐȸÁö
ÀڱñÙÁ¾ ȯÀÚ¿¡¼ GnRH À¯»çü Åõ¿©ÈÄ ÀڱñÙÁ¾ ¼¼Æ÷Áõ½Ä¿¡ °üÇÑ ¿¬±¸. À̺´¼® À̺¸¿¬ ¹Ú±âÇö Á¶µ¿Á¦ À̱¹ ¼ÛÂùÈ£ ±èÈ£±Ù. 1992:19:2:175-179 ´ëÇѺÒÀÓÇÐȸÁö
ºÎÀΰúȯÀÚ¿¡¼ Resectoscopy ÀÇ ÀÀ¿ë. ¼ÛÂùÈ£ ¹Ú±âÇö À̺´¼® À̺¸¿¬ Á¶µ¿Á¦. 1992:4:1 11-17 ´ëÇÑ»êºÎ³»½Ã°æÁö
* The data above are summarized for a personal filing at Jan. 2010. Not proven for public / official reports.